Cargando…

Rapid Detection of Anti-SARS-CoV-2 Antibody Using a Selenium Nanoparticle-Based Lateral Flow Immunoassay

Coronavirus disease 2019 is an infectious disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). SARS-CoV-2 is highly transmissible. Early and rapid testing is necessary to effectively prevent and control the outbreak. Detection of SARS-CoV-2 antibodies with lateral flow...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IEEE 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8905607/
https://www.ncbi.nlm.nih.gov/pubmed/34406945
http://dx.doi.org/10.1109/TNB.2021.3105662
_version_ 1784665224599568384
collection PubMed
description Coronavirus disease 2019 is an infectious disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). SARS-CoV-2 is highly transmissible. Early and rapid testing is necessary to effectively prevent and control the outbreak. Detection of SARS-CoV-2 antibodies with lateral flow immunoassay can achieve this goal. In this study, SARS-CoV-2 nucleoprotein (NP) was expressed and purified. We used the selenium nanoparticle as the labeling probe coupled with the NP to prepare an antibody (IgM and IgG) detection kit. The detection limit, cross reaction, sensitivity and specificity of the kit is verified. Separate detection of IgM and IgG, such as in this assay, was performed in order to reduce mutual interference and improve the accuracy of the test results.The final purity of NP was 91.83%. Selenium nanoparticle and NP successfully combined with stable effect. The LOD of the kit was 20 ng/mL for anti-NP IgG and 60 ng/mL for anti-NP IgM, respectively. The kit does not cross reaction with RF. The sensitivity of the kit was 94.74% and the specificity was 96.23%. The assay kit does not require any special device for reading the results and the readout is a simple color change that can be evaluated with the naked eye. This kit is suitable for rapid and real-time detection of the SARS-CoV-2 antibody IgG and IgM.
format Online
Article
Text
id pubmed-8905607
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher IEEE
record_format MEDLINE/PubMed
spelling pubmed-89056072022-03-31 Rapid Detection of Anti-SARS-CoV-2 Antibody Using a Selenium Nanoparticle-Based Lateral Flow Immunoassay IEEE Trans Nanobioscience Article Coronavirus disease 2019 is an infectious disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). SARS-CoV-2 is highly transmissible. Early and rapid testing is necessary to effectively prevent and control the outbreak. Detection of SARS-CoV-2 antibodies with lateral flow immunoassay can achieve this goal. In this study, SARS-CoV-2 nucleoprotein (NP) was expressed and purified. We used the selenium nanoparticle as the labeling probe coupled with the NP to prepare an antibody (IgM and IgG) detection kit. The detection limit, cross reaction, sensitivity and specificity of the kit is verified. Separate detection of IgM and IgG, such as in this assay, was performed in order to reduce mutual interference and improve the accuracy of the test results.The final purity of NP was 91.83%. Selenium nanoparticle and NP successfully combined with stable effect. The LOD of the kit was 20 ng/mL for anti-NP IgG and 60 ng/mL for anti-NP IgM, respectively. The kit does not cross reaction with RF. The sensitivity of the kit was 94.74% and the specificity was 96.23%. The assay kit does not require any special device for reading the results and the readout is a simple color change that can be evaluated with the naked eye. This kit is suitable for rapid and real-time detection of the SARS-CoV-2 antibody IgG and IgM. IEEE 2021-08-18 /pmc/articles/PMC8905607/ /pubmed/34406945 http://dx.doi.org/10.1109/TNB.2021.3105662 Text en https://creativecommons.org/licenses/by/4.0/This work is licensed under a Creative Commons Attribution 4.0 License. For more information, see https://creativecommons.org/licenses/by/4.0/
spellingShingle Article
Rapid Detection of Anti-SARS-CoV-2 Antibody Using a Selenium Nanoparticle-Based Lateral Flow Immunoassay
title Rapid Detection of Anti-SARS-CoV-2 Antibody Using a Selenium Nanoparticle-Based Lateral Flow Immunoassay
title_full Rapid Detection of Anti-SARS-CoV-2 Antibody Using a Selenium Nanoparticle-Based Lateral Flow Immunoassay
title_fullStr Rapid Detection of Anti-SARS-CoV-2 Antibody Using a Selenium Nanoparticle-Based Lateral Flow Immunoassay
title_full_unstemmed Rapid Detection of Anti-SARS-CoV-2 Antibody Using a Selenium Nanoparticle-Based Lateral Flow Immunoassay
title_short Rapid Detection of Anti-SARS-CoV-2 Antibody Using a Selenium Nanoparticle-Based Lateral Flow Immunoassay
title_sort rapid detection of anti-sars-cov-2 antibody using a selenium nanoparticle-based lateral flow immunoassay
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8905607/
https://www.ncbi.nlm.nih.gov/pubmed/34406945
http://dx.doi.org/10.1109/TNB.2021.3105662
work_keys_str_mv AT rapiddetectionofantisarscov2antibodyusingaseleniumnanoparticlebasedlateralflowimmunoassay
AT rapiddetectionofantisarscov2antibodyusingaseleniumnanoparticlebasedlateralflowimmunoassay
AT rapiddetectionofantisarscov2antibodyusingaseleniumnanoparticlebasedlateralflowimmunoassay
AT rapiddetectionofantisarscov2antibodyusingaseleniumnanoparticlebasedlateralflowimmunoassay
AT rapiddetectionofantisarscov2antibodyusingaseleniumnanoparticlebasedlateralflowimmunoassay
AT rapiddetectionofantisarscov2antibodyusingaseleniumnanoparticlebasedlateralflowimmunoassay
AT rapiddetectionofantisarscov2antibodyusingaseleniumnanoparticlebasedlateralflowimmunoassay
AT rapiddetectionofantisarscov2antibodyusingaseleniumnanoparticlebasedlateralflowimmunoassay
AT rapiddetectionofantisarscov2antibodyusingaseleniumnanoparticlebasedlateralflowimmunoassay
AT rapiddetectionofantisarscov2antibodyusingaseleniumnanoparticlebasedlateralflowimmunoassay
AT rapiddetectionofantisarscov2antibodyusingaseleniumnanoparticlebasedlateralflowimmunoassay
AT rapiddetectionofantisarscov2antibodyusingaseleniumnanoparticlebasedlateralflowimmunoassay